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Introduction
Approximately 53 million Americans live with a disability. For decades, the National 
Institutes of Health (NIH) have been conducting and supporting research to discover new 
ways to minimize disability and enhance the quality of life of people with disabilities. After 
the passage of the American with Disabilities Act (ADA), the NIH established the National 
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Center for Medical Rehabilitation Research (NCMRR) with the goal of developing and 
implementing a rehabilitation research agenda. Currently, a total of 17 institutes and centers 
at NIH invest more than $500 million per year in rehabilitation research. Recently, the 
Director of NIH, Dr. Francis Collins, appointed a Blue Ribbon Panel to evaluate the status of 
rehabilitation research across institutes and centers. As a follow-up to the work of that Panel, 
NIH recently organized a conference under the title “Rehabilitation Research at NIH: 
Moving the Field Forward”. This report is a summary of the discussions and proposals that 
will help guide rehabilitation research at NIH in the near future.
The Conference took place at the NIH Campus on May 25 and 26, 2016. It was co-
sponsored by The Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, the National Institute of Biomedical Imaging and Bioengineering, the 
National Institute of Neurological Diseases and Stroke, the National Institute of Nursing 
Research, the National Institute on Deafness and other Communication Disorders, the 
National Center for Complementary and Integrative Health, and the Office of Disease 
Prevention. The main objectives of the Conference were to: 1) discuss the current NIH 
portfolio in rehabilitation research, 2) highlight advances in rehabilitation research supported 
by NIH, 3) provide an opportunity for scientists and the general public to comment on gaps 
in knowledge, opportunities for training, and infrastructure needs. The program included a 
total of 13 expert panels, 4 remarks by NIH leaders, a consumer keynote, a town hall, a 
poster session, and the use of social media to disseminate information in real time. The 
following is a summary of the discussion and the sub-headings correspond to the title of the 
expert panels.
Rehabilitation across the lifespan
(Moderator: Alan Jette, Ph.D., Boston University; Panelists: Andrea Cheville, M.D., Mayo 
Clinic; Jonathan Bean, M.D., Boston University; Shari Wade, Ph.D., Cincinnati Children’s 
Hospital Medical Center)
The theme of this session was moving rehabilitation interventions from a traditional ‘one-
and-done’ isolated model of care to one where rehabilitation interventions are integrated into 
the mainstream of health care. The speakers addressed integrated care approaches in cancer 
care, primary care, and pediatric rehabilitation.
Barriers to integrating function-directed care into the comprehensive management of 
progressive diseases, particularly those with a heavy treatment burden, were identified. 
Cancer was used an exemplar of the simultaneously dynamic and insidious nature of 
disablement in chronic illness. Collaborative care approaches, including telecare, validated 
for pain and depression management, was considered a promising means to proactively and 
patient-centrically address cancer-related disablement. Current research in cancer 
rehabilitation suggests that challenges revolve around issues such as: patient selection and 
timing, when and how to intervene, limitations of linear impairment-to- disability models 
(with multiple mild impairments the norm), and competition with disease-modifying 
therapies. Although functional limitations are prevalent (seen in 65% of all cancer patients) 
rehabilitation intervention remains underutilized. In contrast to ischemic and traumatic 
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injuries, rehabilitation interventions in patients with cancer are less prescriptive, more 
negotiable, and subject to patient preferences. Current care delivery overwhelmingly 
emphasizes primary disease management.
Another presentation focused on limitations with mobility tasks, such as walking, rising 
from a chair or climbing stairs, as a signal condition identifying older adult primary care 
patients at an increased risk for disability, morbidity and death. It was discussed how 
rehabilitative care can play a critical role with older adult primary care patients by 
developing integrated care paradigms between primary and rehabilitative care providers 
focused on prevention of mobility decline among older adults. Prevention of adverse health 
outcomes represents a new conceptual role for rehabilitative care. Research priorities include 
determining the optimal content and design of preventative rehabilitative care, the potential 
benefits for patients, families and healthcare organizations and the cost/benefit of such 
approaches to care.
Traumatic brain injury (TBI) was used as a case example to discuss the need for further 
research on ways to integrate pediatric rehabilitation into the broader framework of child 
development. TBI is currently viewed as a discrete event with time limited consequences 
while evidence from TBI Model Systems suggests lifelong physical and cognitive 
consequences. Long-term pediatric studies are lacking, but existing evidence suggests long-
term effects on educational attainment and vocational and social success. However, after the 
post acute recovery phase, children with TBI receive little ongoing rehabilitation. TBI-
related problems that emerge with shifting developmental demands may go unrecognized or 
be inaccurately characterized. Families and schools constitute powerful contexts for ongoing 
rehabilitation and later habilitation. How families function and interact with the child exerts 
a powerful influence on the recovery trajectory. Interventions need to be developmentally 
tailored and address the current developmental and neural context. Challenges remain in 
framing rehabilitation/habilitation as an ongoing process with tune-ups at various 
developmental stages rather than a one and done model. Better understanding of adult 
outcome metrics (for example education and employment) and long-term burden (disability 
and life quality). To reduce heterogeneity and improve prediction, research is needed to 
better categorize the initial injury/insult along with better understanding of effects on 
neurodevelopment and how this relates to long-term functional outcomes. Multi-center 
consortiums are urgently needed to support larger scale outcome studies and provide an 
infrastructure to link school and medical data as well as study interventions and management 
practices more efficiently.
Technology in rehabilitation: from cutaneous to implanted
(Moderator: Ranu Jung, Ph.D., Florida International University; Panelists: Leigh 
Hochberg, M.D., Ph.D., Harvard University; Reggie Edgerton, Ph.D., University of 
California, Los Angeles; Joseph Rizzo, M.D., Harvard University; Mario Svirsky, Ph.D., 
New York University)
Innovation and advances in engineering and computing are having a ubiquitous impact on 
health and well-being. The purpose of this panel was to discuss challenges and opportunities 
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for developing technologies that interface with the nervous system at an appropriate level, 
are user-centric and responsive to the ability of the user and their life-span, and could 
provide new neuroscience insights to inform rehabilitation science. The panel also discussed 
the importance of having appropriate assessment methodologies and comprehensive 
engagement with regulatory, industry and clinical partners. The moderator and panelists 
brought to the discussion their experience as neuroscientists, biomedical engineers and 
clinical practitioner, some with personal experience of moving neurotechnology from the 
laboratory to human studies. Using examples from engineering of cochlear and visual 
prosthetic devices, brain, spinal cord and peripheral nerve interfaces they discussed the role 
of technology in scientific discovery and recovery and restoration of missing or lost 
function.
The overall span of the technology that can influence rehabilitation is broad: from assistive 
devices, rehabilitation robotics and implanted neuroprostheses to augmented connectivity 
between people and devices, use of virtual reality environments for training, and use of 
mobile health and tele-health platforms for deployment of rehabilitative therapies. The panel 
discussions focused on implanted neuroprostheses. Advances in neurotechnology will allow 
us to better access information about the living system at multiple scales from cellular to 
behavioral. Improved understanding of the endogenous activity patterns of neural activity 
could help guide the design of neuroprostheses that can more precisely influence and modify 
the neural activity to initiate and sustain long-term beneficial neuroplasticity leading to 
repair or recovery. Design, development and deployment of the neuroprostheses that form 
biohybrid systems with the living body has many challenges.
A major challenge in the deployment of neuroprostheses that effect recovery is to make the 
neuroprostheses adaptive and patient-centric. The panel discussed that the scheduling 
(timing) for introducing rehabilitation technology after a traumatic event to patients is very 
important. Additionally, whether all of the capabilities for the neurotechnology should be 
introduced immediately or in a controlled sequential manner after deployment has to be 
considered. For example, after a bilateral sequential implantation of cochlear implants, 
should they be deployed sequentially or together? To restore function after incomplete spinal 
cord injury should epidural stimulation be conducted in parallel with or prior to treadmill 
training? Recovery of function is very patient specific and may confound assessment of the 
effectiveness of different neural stimulation paradigm interventions. To design appropriate 
rehabilitation therapies, conduction of scientific studies in tandem with technology 
development would be highly beneficial. This in itself raises new challenges.
Several of the technological interventions could require extensive development and the 
underlying science of rehabilitation may be insufficient to support the use of these 
technologies for larger-scale human use. It is essential that early development of 
neurotechnologies, including the scientific studies that provide the evidence, are conducted 
with close consultation of the regulatory bodies such as the Food and Drug Administration. 
Safety and reliability small early-feasibility-trials need to be considered. In this context, the 
panel suggested that for sequential improvements in technology a modular design be 
utilized. Additionally, giving the participant at least some control over use of the technology 
as needed was considered important. This requires the development of a regulatory 
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acceptance pathway. There was considerable discussion on design of study protocols with 
small numbers of enrolled participants. Each participant’s own abilities with turning on or 
shutting off the device could be utilized as an internal control for device evaluation, thereby 
formalizing and extending the value of small studies. The lack of commercial support for 
conducting small subject studies with the associated legal and regulatory requirements 
indicates that governmental funding support for technology development and early-
feasibility trials is paramount for translation of the neurotechnologies from the laboratory to 
the clinic.
A key outcome from the panel discussion was that implanted neurotechnologies offer a 
“precision medicine” approach to rehabilitation. They target specific neural populations. The 
stimulation paradigms could be combined with other treatments, especially cell therapies, to 
maximize function. This ability for precision deployment could be further tailored to take 
advantage of the genetic makeup of the recipient to make it a personalized, adaptive 
approach to rehabilitation.
Mechanisms and markers of activity and function
Exercise, Plasticity, and Mechanism: How is Rehabilitation Happening?
(Moderator: Keith Tansey, M.D., Ph.D., Methodist Rehabilitation Center; Panelists: Rick 
Lieber, Ph.D., Rehabilitation Institute of Chicago; Stephen Seliger, M.D., University of 
Maryland; James Blumenthal, Ph.D., Duke University)
Rehabilitation interventions are applied to various patient populations with diverse 
physiological profiles over extended periods of time with relatively little evidence regarding 
how which interventions are doing what in whom. Patients with neurological problems need 
to be characterized better so that we can identify and analyze responders vs. non-responders. 
Monitoring tools to ensure that rehabilitation interventions are proceeding towards more 
normal physiology over time are also needed. Neurological plasticity after injury can be both 
adaptive and maladaptive and we need to work to gain the former while limiting the latter. 
Similarly, skeletal muscle plasticity is important in injury and rehabilitation but classic 
measures rarely capture the functionally relevant properties of skeletal muscle. Most 
plasticity studies focus on muscle active properties such as force generation and fatigue and 
less so on problems involving passive mechanical properties due to contracture or fibrosis. 
New areas of investigation in the field include extracellular matrix structure and function and 
the development of new imaging methods that would permit meso-scale quantitative 
measures of muscle performance that are objective and clinically relevant. Older adults with 
chronic kidney disease have impaired neurocognitive function, physical performance, and 
aerobic capacity. Research has been done on the mechanisms associating kidney disease to 
physical and cognitive impairment. Exercise training improves neurocognitive function and 
protects against cognitive decline in chronic renal disease patients. Finally, patients 
undergoing cardiac rehabilitation benefit from stress management. The ENHANCED trial 
shows the beneficial effects of combining stress management training with standard 
exercise-based cardiac rehabilitation in terms of stress levels, coronary heart disease 
biomarkers, and clinical outcomes. These findings should be disseminated and cardiac 
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rehabilitation program including stress management should be made more accessible to 
patients with coronary heart disease.
The major issues identified and questions raised in this session for further consideration 
going forward were as follows. We have to address diverse populations (physiologically) in 
rehabilitation, even within a given diagnosis. We also need to address our lack of 
mechanistic understanding of interventions, in pre-clinical and clinical scenarios, which 
makes predicting responders vs. non-responders difficult and makes translation from animal 
model to human problematic as well. The idea of tracking progression during an 
intervention was introduced: Are we generating more normal biology/function or developing 
“work arounds” in rehabilitation? The question was raised as to whether we are measuring 
the right biological markers in our systems, the ones that are actually critical to the 
pathophysiology/impaired function, so as to develop appropriate interventions. We may need 
to develop better assessment tools (imaging for instance) to understand these issues. We may 
also need to connect previously unconnected areas of medicine (chronic disease states and 
their neurological impact for instance) to make a wider impact with our interventions. 
Finally, we should partner psychological interventions with rehabilitation interventions to 
have a greater impact overall on human health.
Access to the lived environment
(Moderator: Melanie Fried-Oken, Ph.D., Oregon Health & Science University; Panelists: 
Cole Galloway, Ph.D., University of Delaware; Maureen Schmitter-Edgecombe, Ph.D., 
Washington State University; James Coughlan, Ph.D., Smith-Kettlewell Eye Research 
Institute)
This panel presented and discussed evidence that assistive technologies (AT) provide 
functional tools to ensure that individuals experience their greatest level of functional 
independence in daily life. Based on the ICF model (WHO, 2001), AT is a facilitator for 
activities and participation for individuals who experience disability and chronic health 
conditions. The technologies being developed and discussed tested by this panel are often 
mainstream technologies available to the general public that are adapted to meet functional 
needs and access to daily environments. Devices, such as off-the-shelf toy racecars that can 
provide mobility to children with physical impairments, environmental controls with 
infrared sensors to support or assess elders with dementia who are aging in place, and 
application software for touch tablets and mobile phones that guide travelers with visual 
impairments at traffic intersections, were discussed and demonstrated through multi-media 
presentations.
The panel discussed three common themes and a number of challenges to the design, testing 
and implementation of assistive technologies including:
1. Participatory action research (PAR) as a critical element of rehabilitation 
research. Individuals with disabilities must be included in all stages of hypothesis 
testing and analysis to ensure content validity. PAR is sensitive to group as well 
as individual differences (i.e., cultural, ethnic, lifestyle diversity) and leads to 
people having increased control over their lives.
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2. The utility of AT for value added to end-users and professionals must become a 
priority for rehabilitation science. Utility measures such as task performance 
(e.g., efficiency and effectiveness of task completion), user satisfaction, and 
quality of life, must become standard. It is challenging to measure value since 
the user population is extremely heterogeneous in terms of needs, abilities and 
preferences. Researchers must determine if it is better to assess utility for a 
narrow population who is most likely to benefit from AT or a broad population, 
where only a subset of individuals is likely to benefit. The variability of user 
population and task conditions can make it very hard and/or costly to get good 
statistics on utility. While statistical success is easier to obtain under controlled 
lab conditions, the lab conditions do not translate to real-world conditions. 
Measurement of user satisfaction (or dissatisfaction) and quality of life, 
constructs that are often used for outcomes, have challenges, as well.
3. AT must be scaled, in terms of sustainability and accessibility, to the population. 
As technology is rapidly advancing, we must try to get at the back end of it even 
as it gets more complex. For example, as infrared sensors became wireless, 
laboratories and smart homes needed to adjust so that our tools are sustainable. 
For the biggest impact, one goal in technology research and development must 
include keeping products and services affordable so they can be accessed by the 
population who needs them. Likewise, we must increase awareness and benefits 
of assistive technologies for the general public. The AT must meet the 
environmental and personal demands of the end users, while protecting privacy, 
maintaining confidentiality and security of personal information.
Individuals, families, and community
(Moderator: Linda Ehrlich-Jones, Ph.D., Rehabilitation Institute of Chicago; Panelists: 
Christopher Murtaugh, Ph.D., Visiting Nurse Service of New York; George Alexopoulos, 
M.D., Cornell University; Sara Czaja, Ph.D., University of Miami Miller School of 
Medicine)
Rehabilitation interventions incorporating the home, the family and the community promote 
active engagement of patients, family and community members to achieve increased quality 
of life for people with disabilities. Psychosocial interventions aimed at reducing post-stroke 
depression and stress rely on five integrated components: 1) offer patients action-oriented, 
“new perspective” about recovery; 2) provide an “adherence enhancement structure”; 3) 
offer a “problem solving structure” to the patient focusing on problems, valued by the 
patient, and pertinent to daily function; 4) help the patient’s family “reengineer its goals, 
involvement, and plans” to accommodate the patient’s disability; and 5) “coordinate care 
with specialized therapists” with the goal to increase patient participation in rehabilitation 
and social activities.
Outcomes of patients receiving physical therapy at home for activity-limiting pain, total hip 
or knee replacements and implantable cardiac devices show some improvement over time. 
Family caregivers play a critical role in supporting older adults and family members with a 
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chronic disease or disability. Intervention strategies that are aimed at supporting family 
caregivers and reducing caregiver burden with an emphasis on technology-based 
interventions are needed to facilitate improved outcomes in people with disabilities. The end 
goal of incorporating the home, the family and the community is greater independence and 
providing opportunities for people with disabilities to actively contribute to their community. 
Strategies that help individuals to self-manage their disability can lead to achievement or 
maintenance of positive outcomes. The challenges experienced by caregivers of individuals 
with disabilities need further attention.
Gaps and opportunities for future research include examination of the impact of socio-
demographic influences, including geography, socioeconomic status, education, and 
language/culture on rehabilitation success. In addition, development of self-management 
strategies that can be implemented in community settings to help individuals better 
understand and manage their disability and achieve or maintain positive quality of life and 
independence are necessary areas of future research.
Understanding the context: environmental impacts in rehabilitation
(Moderator: Michael Mueller, Ph.D., Washington University School of Medicine; 
Panelists: James Burke, M.D., University of Michigan; Amanda Botticello, Ph.D., M.P.H., 
Kessler Foundation; Patrick Kitzman, Ph.D., University of Kentucky)
The purpose of this session was to consider how environmental factors impact outcomes in 
rehabilitation. The “environment” is an important, modifiable, and understudied element in 
the International Classification of Functioning, Disability and Health (ICF) framework. An 
example was provided for patients with diabetes and peripheral neuropathy that illustrated 
how a conceptual framework had been used to help direct interventions at the environmental 
level (casting, footwear, community screening and education) to reduce the rate of lower 
extremity amputation. Other, more complex models are being developed to illustrate ways in 
which race and socioeconomic factors may interact with contextual factors such as caregiver 
support, transportation, neighborhood environment and social network to limit access to 
rehabilitation. Some drivers of racial differences in post-stroke disability are modifiable and 
we should consider stroke survivor and family level strategies to reduce disability and 
decrease disparities.
There are links between community context and long-term outcomes for persons with spinal 
cord injury (SCI). Community characteristics such as socioeconomic disadvantage, resource 
deprivation, segregation, and physical inaccessibility likely threaten the physical, 
psychological, and social functioning gains achieved during rehabilitation. Neighborhood 
socioeconomic factors affect health and well being over and above personal characteristics. 
For example, employment rates for SCI are poor with rural < suburban < urban. The best 
prospects for employment and community participation are for those people with SCI and 
high socioeconomic status in urban environments. The challenge of providing rehabilitation 
services to people with SCI in rural settings was highlighted with a description of a specific 
program targeting rural Kentucky, a state at the bottom of several US health outcome 
measures. The Kentucky Appalachian Rural Rehabilitation Network (KARRN) is working 
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to overcome these barriers and encourages a bidirectional flow of information, providing 
clear benefits for the community, being accountable and providing long-term commitment 
(i.e., sustainability) to the community.
All presentations and discussion highlighted the fact that interactions between environment 
and outcomes are highly complex and vary according to location, socioeconomic level, race, 
age, and disability. Understanding these complex relationships will require further 
refinement of conceptual models and a variety of research approaches to understand 
outcomes and devise policy to enhance outcomes. The use of “big data sets” is useful and 
the net of these data sets need to be spread even further to capture common concerns across 
wide geographical areas. Consistent with other sessions, there is a need for common 
outcome measures but also for qualitative studies to better understand these themes at an 
individual level. Finally, another important theme was the need for ongoing support for 
people with chronic disabilities. Longitudinal research is needed to determine how disability 
affects people in their environment over time. Intervention should not be “one and done” but 
should dynamically meet the ongoing and changing needs of people with chronic health 
problems.
Effective pathways to evidence for rehabilitation
(Moderator: James Malec, Ph.D., Indiana University School of Medicine/Rehabilitation 
Hospital of Indiana; Panelists: Lynn Snyder-Mackler, P.T.,Sc.D., University of Delaware; 
Catherine Lang, Ph.D., Washington University; Susan Horn, Ph.D., University of Utah)
This symposium examined phases, options, and challenges in advancing a line of 
rehabilitation research. Methodologies for addressing challenges were explored as well as 
for incorporating mechanisms, defining dose, and examining the effectiveness of standard 
rehabilitation procedures.
Traditional phases in a line of research include idea generation, natural history and/or animal 
models, early human testing for safety and feasibility, efficacy trials, and effectiveness trials. 
This sequence may be most informative if viewed as iterative and recursive rather than 
linear. Designs such as, the randomized controlled trial (RCT) offer strong internal validity. 
However, some aspects of the RCT, for example, participant and researcher blinding and 
development of a viable control condition, may be difficult to implement in rehabilitation 
research. Other designs, such as, large-scale observational or Practice-Based Evidence 
(PBE) trials, may offer stronger external validity. Balancing internal and external validity is 
critical to encourage timely translation into practice. Other considerations and challenges in 
advancing rehabilitation research include heterogeneity of participants and interventions 
(which are typically individualized in practice), fidelity assurance, dosing, consideration of 
nonspecific factors as moderators as opposed to confounders of treatment effect, and the 
precision of measurement tools used to assess outcomes that are not directly observable and 
must be assessed by observer or participant rating.
Investigating underlying mechanisms of action in high quality clinical trials and 
observational quasi-experimental studies within rehabilitation research is achievable, but 
Frontera et al. Page 9
Am J Phys Med Rehabil. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
fraught with obstacles that do not occur in typical clinical drug trials. Unlike the delivery of 
an active medication or placebo, rehabilitation interventions are typically multimodal and 
involve active participation of both the patient and the clinicians. Thus, assuring fidelity, that 
is, defining the intervention(s), assuring that the intervention(s) are reliably applied and 
defining the active component(s), is particularly challenging in studies of rehabilitation. Use 
of fidelity metrics, ideally completed by more than one observer, address this challenge. In 
rehabilitation research, outcomes are often complex, occur across the domains of the 
International Classification of Function (ICF) and include patient-reported as well as 
performance-based and instrumented outcomes. Consequently, strategic selection and 
pretrial testing of precision outcome metrics and control conditions is critical.
It is also critical to consider dosing in rehabilitation trials in order not to waste resources and 
to eventually improve outcomes. In rehabilitation, dose is an interaction of multiple 
parameters. Explicit studies of dose-response are necessary to determine essential 
information about active ingredients, their biological targets and mechanisms of action, and 
their half-lives. As with other elements of high quality clinical trials, key dosing parameters 
are best determined through pretrial feasibility study. Methods to determine appropriate dose 
include (1) careful quantification of the active ingredient, (2) multiple assessments over the 
course of the intervention, (3) multiple groups receiving different doses, and (4) 
sophisticated statistical modeling of data across time (e.g., hierarchical linear modeling, 
individual growth curve analysis).
Electronic medical records (EMRs) are collecting detailed patient, treatment, and outcome 
data now and will do so even more in the future. This information can be used to determine 
those interventions that are associated with better outcomes for patients with specified sets 
of characteristics through PBE study designs. PBE is an example of an innovative research 
methodology that addresses many of the challenges to the traditional RCT posed by 
rehabilitation research.
This symposium identified a number of challenges to interventional rehabilitation research 
including heterogeneity of participants, individualized and complex treatments, balancing 
internal and external validity, implementing viable control conditions, difficulty blinding 
participants and researchers, nonspecific treatment moderators, fidelity assurance, and 
dosing. A greater emphasis on pretrial studies and alternative designs to the traditional RCT 
offer opportunities to address many of these challenges.
Central and peripheral mechanisms of rehabilitation
(Moderator: Rick Lieber, Ph.D., Rehabilitation Institute of Chicago; Panelists: D. Michele 
Basso, Ph.D., Ohio State University; Monica Perez, Ph.D., University of Miami; Mike 
Boninger, M.D., University of Pittsburgh)
In this session, the mechanisms of plasticity in rehabilitation were discussed. The presenters 
focused on approaches to measuring brain, spinal cord, and skeletal muscle function and 
discussed how rehabilitation and regenerative therapies could be applied to improve central 
and peripheral function.
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Human skeletal muscle adapts to contractures that occur secondary to stroke and cerebral 
palsy. Intraoperative structural studies of upper extremity muscles show that sarcomere 
length increased while serial sarcomere number decreased dramatically. The extracellular 
matrix (ECM) in contractures was deranged (hypertrophic and altered composition) and, 
apparently, does not support a functional stem cell niche. Using both flow assisted cell 
sorting (FACS) and immunohistochemistry, it has been demonstrated that satellite cell 
number (muscle stem cells) are decreased by about 70% in contractures. This may cause 
muscle shortening, deranged ECM, and increased muscle stiffness. Finally studies of gene 
expression from these muscles revealed altered transcriptional pathways relative to other 
models of decreased use such as immobilization, spinal cord injury or spaceflight. Thus, 
muscle contracture represents a dramatic and unique model that must be understood 
mechanistically in order to develop novel treatment approaches.
Studies at the cellular level may explain why SCI rehabilitation can be quite effective in 
some individuals while others show limited improvement. In rodent models of contusion, the 
timing to deliver task-specific training and cellular factors that are conducive to motor 
learning has been determined. These findings suggest that inflammation in cord regions 
remote to the injury is a barrier to effective rehabilitation. In fact, animal models show that 
training delivered early after SCI during high inflammation worsens function but reducing 
this inflammation allows robust locomotor recovery using a brief training paradigm. The 
source and genetic profiles of cellular inflammation have been identified which may allow 
development of biomarkers for rehabilitation.
New neuroplasticity protocols are being used in humans with SCI and non-invasive 
electrophysiology can be used to guide therapeutic interventions. The corticospinal tract is 
an important target for motor recovery after SCI. Noninvasive techniques have been used to 
develop tailored protocols for precise timing of the arrival of descending and peripheral 
volleys at corticospinal synapses of upper and lower limb muscles in humans with chronic 
partial paralysis. Voluntary motor output depends on the efficacy of synapses between 
corticospinal axons and spinal motor neurons, which can be modulated by precise timing of 
central and peripheral neuronal spikes. Thus, noninvasive techniques can be used to develop 
tailored protocols for precise timing of the arrival of descending and peripheral volleys at 
corticospinal-spinal motor neuron synapses involved in intrinsic finger muscle function in 
humans with chronic incomplete SCI. Using electrophysiological measurements by 
stimulating different levels of the corticospinal pathway in individual subjects, accurate 
estimates of the time of arrival of action potentials to the muscle have been measured; 
indeed latencies of EMG responses relied on the generation of action potentials in motor 
neurons. The results indicate that arrival of presynaptic volleys prior to motor neuron 
discharge enhances corticospinal transmission and hand voluntary motor output. In contrast, 
the reverse order of volley arrival and sham stimulation does not decrease voluntary motor 
output and electrophysiological outcomes. Overall, these findings demonstrate that spike 
timing-dependent plasticity of residual corticospinal-spinal motor neuron synapses provides 
a mechanism to improve motor function after SCI. Modulation of residual corticospinal-
spinal motor neuron synapses may present a novel therapeutic target for enhancing voluntary 
motor output in motor disorders affecting the corticospinal tract.
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The integration of principles and approaches in rehabilitation science and regenerative 
medicine may help us develop innovative and effective methods that promote the restoration 
of function through tissue regeneration and repair. The application of rehabilitation protocols 
in combination with cellular therapeutics for the treatment of injured or diseased tissue 
enhances transplantation efficacy and improves functional outcomes. While it is clear that 
the convergence of rehabilitation approaches with regenerative medicine strategies will 
accelerate the science underlying tissue restoration after injury and disease, collaborative 
research efforts across the fields of regenerative medicine and rehabilitation are greatly 
lacking. An NIH reporter search of active funding using the Boolean terms “regenerative 
medicine” yielded over 2231 studies. When we modified this search to only include 
“Physical Medicine and Rehabilitation” and “Other Health Professions”, which include 
physical therapy, occupational therapy, and speech language pathology departments, only a 
total of 16 grants were displayed. This is remarkable considering the promotion of tissue 
healing and regeneration is a primary goal of many rehabilitation interventions. There is, 
therefore, a great need to expand scientific knowledge, expertise and methodologies across 
the domains of rehabilitation science and regenerative medicine, with the ultimate goal of 
improving the lives of individuals with disabilities.
Gaps in our understanding of mechanisms underlying rehabilitation include the following 
questions: 1) what has the greatest impact on skeletal muscle strength, the nervous system or 
the biomechanical manipulation of muscle?, 2) which stem cell populations can 
rehabilitation professionals realistically manipulate?, 3) how can exercise influence the stem 
cell population?, 4) how do bio-scaffolds interact with stem cells?, 5) since timing of SCI 
treatment is an important factor in good outcomes, how will we be able to translate animal 
studies into human treatments?, 6) what are the most appropriate strategies for applying 
regenerative medicine to rehabilitation?, 7) does the cellular state of the CNS dictate the 
response to rehabilitation treatment or can the right type of exercise modify the cellular 
environment to create permissive learning conditions?
Bending the arc of technology toward rehabilitation and health
(Moderator: Aiko Thompson, Ph.D., Medical University of South Carolina; Panelists: 
Steve Cramer, M.D., University of California, Irvine; James Rimmer, Ph.D., Lakeshore 
Foundation; Susan Magasi, Ph.D., University of Illinois at Chicago)
The purpose of this session was to discuss how the integration of technology into 
rehabilitation, healthcare, and wellness services can promote better communication between 
healthcare professionals and patients, and thereby achieve healthy lifestyles and better 
quality of life.
The use of information and communication technologies (ICT) eliminates distance barriers 
and can make rehabilitation and healthcare services available to people who have limited 
access to transportation and other access issues. In recent years, digital health (e.g., 
telehealth, telerehabilitation (telerehab), eHealth (healthcare services delivered or enhanced 
through the Internet), and mHealth (delivery of healthcare services via mobile 
communication devices)) is becoming a significant part of the healthcare and healthcare 
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economy. Digital health funding has been steadily increasing. Tools for developing and 
implementing mobile healthcare services and research applications are becoming more and 
more available. It is clear that the use of ICT can broaden rehabilitation and healthcare 
research opportunities for researchers and service opportunities for patients. In this session, 
the speakers provided three levels of remote rehabilitation training management: full 
management (by healthcare professions), middle-level management, and self-management 
(by patients). These different levels are not mutually exclusive, but harmonious approaches 
that allow the patient to transition from one level of management to another, based on his/her 
progress in recovery and changes in needs for care and services.
Many patients do not receive enough dose of rehabilitation therapy after stroke. Telerehab is 
ideally suited to maximize the gains from therapy; for instance, telerehab can increase the 
duration and intensity of therapy and therefore contribute to greater functional gains. Pilot 
studies and clinical trials are ongoing (Cramer) on a home-based telerehab system for 
patients with stroke. Telerehab also offers the option for a holistic approach to patient care, 
for example, incorporating education, sensor data collection, and regular structured 
interactions with therapists.
Other technologies such as eHealth and mHealth can contribute to health promotion 
emphasizing self-care rather than expert care. In furthering the view that digital health 
technologies can help to overcome existing healthcare problems (e.g., lack of integration and 
coordination across different disciplines and accessibility barriers), it was suggested that 
telerehab may prevent well-known post-rehab health decline as the patient transitions from 
dependence to independence. Preliminary findings of the ongoing project (Rimmer), “TExT-
ME: Telehealth Exercise Training for Monitoring and Evaluation of Home-Based Exercise,” 
show that home-based teleexercise interventions can achieve better participant adherence 
than conventional onsite exercise programs, leading to better health benefits. Participants of 
this teleexercise program reported that the convenience and online interaction with a 
telecoach enhanced their motivation to attend the sessions. This telecoaching (i.e., mid-
management) model may become a precursor to self-management and mHealth for 
optimizing recovery in people with neuromuscular disability.
On the other hand the expansion of smartphone use and the app design is literally placing 
sophisticated rehabilitation interventions in the hands of people with disabilities. Potential of 
mRehab applications include symptom monitoring, real time data capture, real time access 
to information about navigating the community, social connectedness through peer to peer 
support, and bi-directional communication. However, there exist barriers to use of mHealth, 
such as limited scientific evidence, lack of integration of multiple perspectives and 
disciplines into workflow, concerns over data confidentiality, privacy and security, and lack 
of provisions for reimbursement. Of particular concerns for the disability community is how 
factors at the human-technology interface can impose barriers to use. Accessibility and 
usability of mRehab interventions are essential factors that must be considered throughout 
the app development. An iterative inter-disciplinary design process that brings together 
content, accessibility, and information technology experts with people with disabilities can 
help ensure the needs and priorities of the disability community.
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Many patients after acquiring a disability are unable to receive the optimal amount of 
rehabilitation and healthcare services due to a number of challenging barriers. With 
continuing growth in the internet and use of smartphones, the development of digital health 
applications can significantly broaden rehabilitation and healthcare opportunities for 
patients. The full potential of digital health technologies to reach a large number of people 
with disabilities who exhibit a range of physical and psychosocial secondary health 
conditions and provide them with effective dose of interventions has yet to be realized.
Transitions across the lifespan
(Moderator: Walter Frontera, MD, PhD, Vanderbilt University; Panelists: Sharon Ramey, 
Ph.D., Virginia Polytechnic Institute and State University; Ellen Giarelli, Ed.D., RN, M.S., 
CRNP, Drexel University; Eric Lenze, M.D., Washington University)
The purpose of this session was to examine current evidence and discuss future research 
needs in the area of rehabilitation across the lifespan with a particular emphasis on 
transitions. Disability has an effect on growth and development, transitions to adulthood, and 
aging (particularly disabling medical conditions). At the same time, these processes can 
influence how individuals adapt to the presence of disability and the nature of their health 
care needs.
The first presentation focused on the need to increase the number of implementation science 
trials to identify approaches and strategies that work best with a high degree of certainty. 
Examples of areas in need of this approach include studies on cost/benefit ratio and health 
disparities. Rapid high fidelity science is needed to put research into practice more quickly. 
In a real world setting it is important to know if the clinician is familiar with the latest 
evidence and the best way to effectively deliver care with high efficiency and consistency. 
We need to understand the barriers and obstacles that prevent research results from being 
implemented. In other words, why does it take so much time and energy to change practice?
Health care, and specifically rehabilitation for patients with chronic syndromes diagnosed in 
childhood including those associated with genetic variants, is best accomplished when it is 
begun early in life, as soon as a diagnosis is pending, conceptualized as requiring the 
integration of skills, knowledge, and clear intentions of a diverse team, and the team is 
composed of the patient, healthcare providers, family members, and other advocates. 
Transitioning of any kind can be complicated and is always highly personal. Further, life-
long management is complex, requires more health care, and is associated with higher costs. 
Therefore we must use models that capture sociocultural, environmental, and health 
variables and barriers to identify paths to, or loci of success. A fundamental goal is 
promoting the patient’s skill at self-surveillance and self-management including 
rehabilitation. There are no tricks, no magic, or fail safe; it is hard work that must be 
individualized and supported.
Aging is associated with significant emotional, cognitive, and/or motivational impairments 
that interfere with successful rehabilitation interventions. Clinical strategies that focus on 
patient engagement and therapy intensity can help with behavioral changes that are needed 
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for successful rehabilitation. A model of Enhanced Medical Rehabilitation (EMR) Therapy 
was presented by Dr. Lenze. This model includes a package of motivational and high-
intensity therapy steps that physical and occupational therapists can take to maximize both 
patient engagement and therapy intensity. Effort and progress is reinforced during therapy 
with direct feedback to the patient and therapy is linked to goals set by the patients. Older 
adults receiving therapy from EMR-trained therapists had greater engagement in therapy 
sessions, higher patient active time, and better functional recovery, compared to patients 
receiving typical standard-of-care therapy.
Novel outcomes in rehabilitation and integration into clinical care
(Moderator: Jonathan Bean, M.D., Harvard Medical School; Panelists: Brad Dicianno, 
M.D., University of Pittsburgh; Melissa Morrow, Ph.D., Mayo Clinic; Brian Hafner, Ph.D., 
University of Washington)
The purpose of this session was to examine the clinical and scientific relevance of 
developing novel outcomes in rehabilitation and its potential to favorably impact the 
changing healthcare environment. Healthcare reform and the shifting emphasis on managing 
health have been coupled with exceptional growth and development in the application of 
technology and engineering to health measurement. As the mobile health field and 
technologies evolve, researchers will continuously be presented with challenges in the 
conceptual design and deployment of clinical trials as well as the conduct of clinical care 
due to the vast array of outcomes measures that can be collected.
The Interactive Mobile Health and Rehabilitation (iMHere) system is an example of a 
mobile health system being used to collect ecological momentary assessment (EMA) 
outcomes data among patients with spina bifida (Diciano). Further, wearable sensors 
monitoring different aspects of health are becoming more widely used in rehabilitation 
research as a method of capturing real world outcomes. For example, sensor based outcomes 
are being utilized (Morrow) in spinal cord injury rehabilitation research although there are 
challenges to the integration of “big data” into clinical practice. New approaches to 
outcomes measurement have also been applied to the development of patient-reported 
outcomes (PROs). National initiatives, like the Patient Reported Outcomes Measurement 
Information System (PROMIS) have resulted in rigorous frameworks for developing PROs 
that can evaluate health outcomes across different patient populations. Efforts utilizing these 
same methods to develop an item bank specific to measuring prosthetic mobility in people 
with lower limb loss were described.
The discussion following the presentations identified a number of issues and challenges. 
These included a number of general issues such as: 1) the importance of developing a 
consolidated infrastructure, be that through industry partnerships or academic hubs; 2) using 
that infrastructure to develop systems that integrate mHealth, wearables, and PROs in 
efficient ways so that they complement each other to optimize assessment and monitoring; 
3) developing strategies to incorporate these integrated data elements into measurement 
systems with which patients and clinicians can optimally engage and interact; and 4) the 
integration of the resulting data into the electronic medical record. Specific needs that were 
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discussed also included: 1) developing “standards” or “best practices” for wearable sensor 
technology akin to what PROMIS had done for PROs; 2) developing strategies for extracting 
the “most important” data from wearable sensors and presenting them in a way that is 
appropriate for the given stakeholder (patients, practitioners, payers); and 3) using these 
approaches for more optimal management of self-care and thus relieving clinicians of the 
burden created by interpreting and processing high volumes of data. Lastly, integrated 
leadership in addressing these concerns was viewed as a priority for NIH, especially in 
cooperation with other relevant agencies such as PCORI, AHRQ or the VHA.
Using data to drive discovery
(Moderator: Ken Ottenbacher, Ph.D., University of Texas Medical Branch; Panelists: 
Adrian Hernandez, M.D., Duke University; James Graham, Ph.D., University of Texas 
Medical Branch; Jennifer Hicks, Ph.D., Stanford University)
The purpose of this session was to examine the use of data as a means to drive discovery. 
Using data to drive discovery has been a hallmark of scientific investigation since the 1600s 
beginning with the writings of Sir Francis Bacon regarding the modern scientific method. 
How data have been defined and used to generate new knowledge has evolved dramatically 
since then. The pace has been particularly rapid during the past decade. This revolution is 
being driven by several factors including: 1) advances in information technology, 2) the 
development of sophisticated data analytics, and 3) the increased availability and complexity 
of data. These factors provide opportunities for data integration, exploration, and secondary 
analysis that did not exist even a few years ago. The National Institutes of Health (NIH) 
“Big Data” program, referred to as BD2K (Big Data to Knowledge) and launched in 2012, is 
a reflection of the data revolution and its impact on biomedical and health care sciences. In 
order for the fields of rehabilitation medicine and disability sciences to fully participate in 
the research opportunities associated with using data to drive discovery there is a need to 
raise awareness and build research capacity.
Significant opportunities exist for data exploration and analyses in existing administrative 
and federal datasets including resources supported by the NIH specifically designed for 
rehabilitation investigators, e.g., Center for Large Data Research & Data Sharing in 
Rehabilitation. In addition, the Mobilize Center, an NIH BD2K Center of Excellence, is 
using modern data science tools to integrate and analyze information from wearable sensors, 
research labs, and clinics to understand and improve human mobility; for example, to 
improve treatment for patients with cerebral palsy. The NIH-funded National Center for 
Simulation in Rehabilitation Research provides the world-wide rehabilitation research 
community with a common platform for sharing data and models that describe movement. 
Additional opportunities for discovery exist using large administrative or public use 
databases such as Medicare claims and assessment files and U.S. Census data (including 
data related to the Affordable Care Act and health care reform). There are rapidly emerging 
opportunities for information sharing and secondary analyses of data from completed studies 
associated with recent federal data sharing and archiving mandates. The use of electronic 
health records and the creation of large data networks and a health system collaborator 
represent yet another opportunity to use clinical data with an emphasis on patient-reported 
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and patient-centered outcomes. Examples included the NIH Collaboratory, National Heart 
Lung and Blood Institute’s Heart Failure Research Network, and the PCORnet: National 
Patient-Centered Clinical Research Network which includes data from more than 100 
million people.
Using data to drive discovery is an important and rapidly expanding area of research with 
enormous potential to advance rehabilitation science and patient care. This session provided 
an introduction to the emerging discipline of Data Science and its application and 
implications for rehabilitation research. A better understanding of Data Science will help 
rehabilitation clinicians, administrators and investigators accomplish the Conference’s goal 
of Moving the Field Forward.
Preventing secondary disability
(Moderator: Diane Damiano, Ph.D., P.T., NIH Clinical Center; Panelists: Greg Hicks, 
Ph.D., University of Delaware; Diann Gaalema, Ph.D., University of Vermont; Sara Mulroy, 
Ph.D., Rancho Los Amigos National Rehabilitation Center)
This session focused on major issues in prevention of secondary disability across 4 distinct 
populations. Children with cerebral palsy, elderly adults with low back pain, adults with 
spinal cord injuries and adults recommended for cardiac rehabilitation programs. Even with 
this diversity, many similarities were seen across the presentations.
The scientific basis across populations for addressing secondary impairments focused on the 
identification of modifiable factors that if addressed would improve outcomes in terms of 
health and functioning for these individuals. For children with CP, the focus was on physical 
activity throughout the lifespan so as to preserve and maintain optimal muscle and brain 
functioning. A particular emphasis was the need to intervene very early in life to limit the 
development of secondary changes due to the inactivity imposed by the brain lesion. For 
elderly adults with low back pain, trunk muscle integrity has been identified as a key 
modifiable factor in this population that can reduce pain. Interestingly, pain was previously 
thought to be an almost inevitable part of normal aging, so much so that older adults were 
typically excluded from studies on LBP. The patients at highest risk for poor outcomes after 
cardiac surgery are often the one who are least likely to attend rehabilitation programs which 
have been shown to be efficacious in improving these outcomes. It is important to identify 
why these individuals chose not to attend with the goal of devising strategies to improve 
their participation. Compliance with rehabilitation or with low term behavioral health 
changes was a theme that resonated across speakers and the audience. Efforts to incentivize 
patients to participate, while expensive, may reduce health care costs tremendously if 
successful. Another patient population with secondary disability is that of individuals with 
spinal cord injuries with shoulder injuries. Using sophisticated biomechanical analyses, 
movement patterns that markedly diminished shoulder pain have been identified, again 
showing that research is needed on modifiable factors that enable people to remain or 
increase their ability to be mobile whether it is in a wheelchair or walking in the community. 
It was emphasized that patients should have greater involvement in our research so we can 
learn their concerns and challenges, their individual factors that make them more likely to 
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have adverse health outcomes. In some instances, it can be socio-economic status, in SCI in 
southern California, living in a violent neighborhood increased the chances markedly of 
having a SCI, both of which present very unique and specific public health challenges in 
addition to the scientific challenges.
Future recommendations for research are to better engage our patients and their needs into 
our research efforts, to be more open to alternative methodologies besides RCTs to find cost-
effective methods to help people maintain their health across the lifespan. From a more 
translational science perspective, we need to know more about mechanisms leading to pain 
across disorders and continue to explore biomechanical and motor learning/training 
strategies to improve functionality and reduce pain rather than masking the chronic pain with 
medication. For children with CP, more effective early intervention strategies need more 
investigation while at the same time the intersection of aging with a disability is also a major 
gap in the literature. Finally secondary disability is hardly secondary in cost, duration and 
importance to patients. However, since it occurs as a result of a primary injury, these could 
theoretically all be avoidable or at least modifiable and this is where rehabilitation research 
is needed.
Development of an NIH Rehabilitation Research Plan
(Presenters: Dr. Alison Cernich and Dr. Lyn Jakeman)
The session covered the development of the new NIH Rehabilitation Research Plan. The 
intent of the plan is to detail research priorities that are of interest to a large group of the 
Institutes and Centers (ICs) in the NIH that invest in rehabilitation research. A trans-NIH 
Medical Rehabilitation Research Coordinating Committee (MRCC) began development of 
the plan in 2015. They developed the priorities in the plan in consultation with the National 
Advisory Board on Medical Rehabilitation Research and the directors of the NIH ICs. NIH 
published a draft of the plan asking for public comment in November of 2015 and revised 
the plan based on that input.
Through feedback received through the request for public input, the MRCC modified the 
plan to include the development of new methods to foster interdisciplinary research, placing 
greater emphasis on health disparities, and broadening the avenues for development of new 
technologies. As a result of the comments, the MRCC added two priority areas and revised 
and refined other priority areas. The final plan includes six priority areas: Rehabilitation 
Across the Lifespan, Family and Community, Technology Use and Development, 
Translational Science, Research Design and Methodology, and Research Capacity and 
Infrastructure. The plan was intended to be final in June and a town hall meeting at the 
conference provided the final opportunity for feedback to the MRCC before the plan was 
published.
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